Acadia Pharmaceuticals (ACAD) Cash & Equivalents (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted Cash & Equivalents of $384.99 million for Q2 2026, up 51.8% from $253.64 million a year earlier and up 36.4% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Acadia Pharmaceuticals' Cash & Equivalents came in at $177.7 million, down 44.4% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -11.4% (FY2020 to FY2025).
- In prior years, Acadia Pharmaceuticals' Cash & Equivalents was $319.59 million in FY2024 (+69.4%), $188.66 million in FY2023 (+64.3%), $114.85 million in FY2022 (-22.1%) and $147.44 million in FY2021 (-54.8%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q3 2020.
- On a year-over-year basis, Cash & Equivalents increased in seven of the last eight quarters, with growth averaging 35.0%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2024, with growth of 69.4%; the weakest was Q3 2021, with a decline of 79.1%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $282.21 million (Q1 2026), $177.7 million (Q4 2025) and $258 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Acadia Pharmaceuticals | 3.50 Bn | 21.37 Mn | 279.64 Mn | 384.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 384.99 Mn |
| Mar 31, 2026 | 282.21 Mn |
| Dec 31, 2025 | 177.70 Mn |
| Sep 30, 2025 | 258.00 Mn |
| Jun 30, 2025 | 253.64 Mn |
| Mar 31, 2025 | 217.70 Mn |
| Dec 31, 2024 | 319.59 Mn |
| Sep 30, 2024 | 155.15 Mn |
| Jun 30, 2024 | 177.13 Mn |
| Mar 31, 2024 | 204.75 Mn |
| Dec 31, 2023 | 188.66 Mn |
| Sep 30, 2023 | 98.19 Mn |
| Jun 30, 2023 | 107.94 Mn |
| Mar 31, 2023 | 290.90 Mn |
| Dec 31, 2022 | 114.85 Mn |
| Sep 30, 2022 | 154.84 Mn |
| Jun 30, 2022 | 139.83 Mn |
| Mar 31, 2022 | 204.92 Mn |
| Dec 31, 2021 | 147.44 Mn |
| Sep 30, 2021 | 94.64 Mn |
API Access
Acadia Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();